genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2010
Receptor tyrosine kinases
Cancer
AVEO Earns $5M Milestone from Biogen Idec as Part of ErbB3 Antibody Collaboration
Cancer
Astellas Pays $40M Up Front to Develop Ambit’s FLT3 Kinase Inhibitors
Insights
Screening Membrane-Associated Targets
Cancer
Biogen Idec Signs Up to Help Aveo Develop Its Discovery-Stage Cancer Program
Insights
Deciphering Biological Networks
News
Cancer Research UK and Astex Choose Anticancer Agent for Development
Insights
Cell Signaling Analysis Using Multiplex Assays
News
Scientists Discover Novel Mechanism for LDL in Heart Attacks
Insights
Improving Drugs with Protein Engineering
News
ArQule Hands Over Asian Rights to Anticancer Drug for $123M
1
...
4
5
6
Page 5 of 6
Scroll Up